Following the 16-day closure of the US federal government, science agencies are catching up on grant reviews. At the NIH, 200 review panels were canceled, affecting the ranking of 11,000 grant applications. In response to researchers’ pleas, the agency will reschedule the panel meetings for the next two months. The NSF was forced to cancel […]
The dependence on Federal stimulus spending along with positive earnings and stronger-than-expected manufacturing data in China elevated US equity markets to new highs in October. The Federal Reserve maintained its bond buying policy citing sluggish employment growth. The probability of any policy change for the remainder of the year is extremely low due to weak […]
New Castle, DE 9/30/13—TA Instruments, a Waters company, has acquired German firm Scarabaeus Mess- und Produktionstechnik for an undisclosed amount. Scarabaeus manufactures instrumentation and software for physical property measurements of rubber and rubber processing. “This market is a natural fit for TA Instruments. We have existing expertise and a large customer base using thermal analysis […]
Middleton, WI 10/11/13—Gilson, a supplier of manual and automated liquid sample management products, has acquired Armen, a provider of manual preparative chromatography based on HPLC and centrifugal partition chromatography, also known as counter current chromatography (CCC). “Armen brings to Gilson their CCC technology, which is capable of quick and cost effective purification of natural, raw […]
Venlo, The Netherlands 10/29/13—QIAGEN has announced the purchase of bioinformatics company CLC bio, which specializes in next generation sequencing (NGS), for an undisclosed amount. CLC bio’s products include the CLC Genomics Workbench for analyzing, comparing and visualizing NGS data and the CLC Genomics Service, an enterprise-level infrastructure and analysis backbone for NGS data analysis. “The […]
San Diego, CA 10/28/13; Washington, DC 10/29/13—Illumina has acquired NextBio, a provider of clinical and genomics informatics, for an undisclosed amount. NextBio’s platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. “The combination of Illumina’s BaseSpace cloud computing environment for next generation sequencing with NextBio’s platform for integrating […]
Branford, CT 10/3/13—According to multiple media reports, Roche will close its 454 Life Sciences subsidiary, which provides DNA sequencers. The New Haven Register reported that the company will shut down by the end of 2015. Manufacturing will cease in 2015 and the sequencers will be phased-out by mid-2016, at which time the company will no […]
In this issue, IBO presents its second of two articles this year detailing developments in patent infringement litigation involving instrument and lab product firms (see IBO 4/30/13). The pace of new litigation appears to have slowed. In addition, new settlements and rulings have put to rest, for now, some long running disputes. New Suits In […]
R&D spending by large pharmaceutical companies is stabilizing despite continued restructuring. However, as pharmaceutical companies continue to streamline R&D, resources are shifting to clinical trials. Forced to balance between cost containment and drug development to secure future revenues, companies are prioritizing investments in drugs with the strongest growth potential, especially for therapies that will both […]
The halogens are a chemical family of reactive nonmetallic elements. Chlorine is the most well-known from its presence in table salt, but the other halogens may also be familiar: fluorine, bromine and iodine. The last halogen, astatine, is radioactive with a short half-life, and thus does not exist in any appreciable quantities. While small amounts […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
